Predictors of latent tuberculosis infection treatment completion in the US private sector: An analysis of administrative claims data

Erica L. Stockbridge, Thaddeus L. Miller, Erin K. Carlson, Christine Ho

Research output: Contribution to journalArticlepeer-review

8 Scopus citations


Background: Factors that affect latent tuberculosis infection (LTBI) treatment completion in the US have not been well studied beyond public health settings. This gap was highlighted by recent health insurance-related regulatory changes that are likely to increase LTBI treatment by private sector healthcare providers. We analyzed LTBI treatment completion in the private healthcare setting to facilitate planning around this important opportunity for tuberculosis (TB) control in the US. Methods: We analyzed a national sample of commercial insurance medical and pharmacy claims data for people ages 0 to 64 years who initiated daily dose isoniazid treatment between July 2011 and March 2014 and who had complete data. All individuals resided in the US. Factors associated with treatment completion were examined using multivariable generalized ordered logit models and bivariate Kruskal-Wallis tests or Spearman correlations. Results: We identified 1072 individuals with complete data who initiated isoniazid LTBI treatment. Treatment completion was significantly associated with less restrictive health insurance, age < 15 years, patient location, use of interferon-gamma release assays, non-poverty, HIV diagnosis, immunosuppressive drug therapy, and higher cumulative counts of clinical risk factors. Conclusions: Private sector healthcare claims data provide insights into LTBI treatment completion patterns and patient/provider behaviors. Such information is critical to understanding the opportunities and limitations of private healthcare in the US to support treatment completion as this sector's role in protecting against and eliminating TB grows.

Original languageEnglish
Article number662
JournalBMC Public Health
Issue number1
StatePublished - 29 May 2018


  • Administrative data
  • Claims data
  • Epidemiology
  • Health service delivery
  • Isoniazid
  • LTBI
  • Latent tuberculosis infection
  • Medication adherence
  • Public health practice
  • Treatment completion


Dive into the research topics of 'Predictors of latent tuberculosis infection treatment completion in the US private sector: An analysis of administrative claims data'. Together they form a unique fingerprint.

Cite this